For months, people with ADHD have been struggling to fill their prescriptions. Federal regulators say the shortage is fueled in part by increasing demand driven by telehealth startups and their aggressive marketing. WSJ’s Rolfe Winkler, who has been investigating two of those companies, explains what an impending rule change could mean for the shortage.
Further Reading:
- Adderall, OxyContin Prescriptions to Require In-Person Doctor Visit Under Biden Plan
- Startups Make It Easier to Get ADHD Drugs. That Made Some Workers Anxious.
Further Listening: